Study on Sanziyangqin Decoction combined with Ambroxol in the treatment of senile chronic obstructive pulmonary disease
三子养亲汤联合氨溴索治疗老年慢阻肺的研究

摘要

目的 探究三子养亲汤与氨溴索联合疗法在老年慢阻肺治疗中的疗效。方法 本研究纳入我院收治的80例老年慢阻肺患者作为研究对象。采用随机数字表法将其均衡分配至对照组（40例，实施氨溴索治疗）与研究组（40例，实施三子养亲汤联合氨溴索治疗）。对两组患者的治疗效果展开对比分析。结果 与对照组相比，研究组患者临床症状的改善时间显著缩短，肺功能指标水平明显更优，中医证候积分则显著更低，差异具有统计学意义（P＜0.05）。结论 在针对老年慢阻肺患者的临床治疗中，采用三子养亲汤与氨溴索联合用药的方案，可有效缩短患者临床症状的缓解周期，同时显著优化其肺功能相关检测指标。

Abstract

Objective To explore the efficacy of Sanzi Yangqin Soup combined with Ambroxol in the treatment of elderly patients with chronic obstructive pulmonary disease (COPD).
Methods This study included 80 elderly patients with chronic obstructive pulmonary disease (COPD) admitted to our hospital as research subjects. Using a random number table method, they were evenly assigned to the control group (40 cases, treated with ambroxol) and the study group (40 cases, treated with Sangzi Yangqin Decoction combined with ambroxol). The treatment outcomes of the two groups were then compared and analyzed.
Results Compared with the control group, the improvement time of clinical symptoms in patients in the study group was significantly shorter, lung function indicators were significantly better, and the Traditional Chinese Medicine syndrome scores were significantly lower, with statistically significant differences (P<0.05).
Conclusion   In the clinical treatment of elderly patients with chronic obstructive pulmonary disease (COPD), the combination of Sanzi Yangqin Decoction and ambroxol can effectively shorten the remission period of clinical symptoms and significantly improve their lung function-related test indicators.